Tuesday, May 20, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology

by
December 27, 2024
in PR Newswire
0
VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

PETALING JAYA, Malaysia, Dec. 27, 2024 /PRNewswire/ — VISTA Eye Specialist (VISTA), Malaysia’s leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low, Medical Director and Ms. Azarina Abdullah, Optometrist has been published in the esteemed Journal of Health Science and Medical Research. This achievement firmly establishes VISTA as a trailblazer in ophthalmology innovation across Southeast Asia.

Dry eye disease is on the rise worldwide, driven by modern lifestyle factors such as prolonged screen time, air-conditioned environments, and aging populations among others. This chronic condition affects millions, causing significant discomfort and diminishing quality of life for sufferers.

Related posts

EVE Energy Hosts Inaugural Commercial Vehicle Battery Technology Day, Unveiling Innovative Open Source Battery Solutions for Full-Range of Commercial Vehicles

EVE Energy Hosts Inaugural Commercial Vehicle Battery Technology Day, Unveiling Innovative Open Source Battery Solutions for Full-Range of Commercial Vehicles

May 20, 2025
Certis unboxes ‘robocop’ as it explores use of humanoid robots

Certis unboxes ‘robocop’ as it explores use of humanoid robots

May 20, 2025

Innovative E>Eye IRPL Therapy

In response to the growing burden of dry eye disease, VISTA is spearheading a revolutionary approach with E>Eye Intense Regulated Pulsed Light (IRPL) therapy, a cutting-edge treatment designed to address evaporative dry eye disease caused by meibomian gland dysfunction (MGD).

The study, titled “The Effectiveness of E>Eye Intense Regulated Pulsed Light Therapy in Treating Evaporative Dry Eye Disease among Southeast Asian Patients,” demonstrates the exceptional efficacy of this advanced therapy in restoring gland function, stabilizing tears, and improving overall eye comfort for patients in the region.

Key Findings of the Research:

Effective with Minimal Treatment: As few as three consecutive sessions of E>Eye IRPL therapy delivered measurable improvements in meibomian gland function and tear stability, providing long-term relief for patients.Tailored for Southeast Asian Needs: The therapy effectively addresses lifestyle and environmental factors specific to the region.Lasting Comfort and Relief: Patients reported significant improvements in their quality of life following treatment.

“Our mission has always been to transform lives through safe, effective, and innovative eye care solutions,” said Dr Aloysius Joseph Low. “Dry eye disease not only causes physical discomfort but also disrupts the ability to fully engage in activities that bring joy and purpose. With E>Eye IRPL therapy, we empower our patients to restore their vision and reclaim their life’s Ikigai – their reason for being.”

Fostering Ikigai Through Vision Health

In Japanese culture, Ikigai refers to the intersection of what you love, what you are good at, what the world needs, and what you can be rewarded for – essentially, living a life of purpose. Vision plays a pivotal role in fulfilling one’s Ikigai, from pursuing meaningful work to enjoying time with loved ones and engaging in personal passions.

VISTA’s innovative treatments, like E>Eye IRPL therapy, are designed not just to treat eye conditions but to enable patients to live fuller, more purposeful lives. Whether it’s regaining confidence in professional pursuits or reconnecting with hobbies and relationships, VISTA’s approach to eye care is deeply aligned with the holistic well-being of its patients.

A Collaborative Innovation

The achievement reflects a strong partnership between VISTA and ESW Vision, the global developer of the E>Eye IRPL system and DED diagnostic unit Tearcheck®. Highlighting this collaboration, Ing. Peter BARANOVIC, MBA – Commercial Director at ESW Vision said:

“We are delighted to collaborate with VISTA Eye Specialist in bringing our Dry Eye Patients Management portfolio of products, such as the diagnostic unit Tearcheck® and E>Eye as IRPL therapy to Southeast Asia. This partnership underscores our shared commitment to advancing dry eye treatment and enhancing patient satisfaction and great outcomes in the region. We as well highly appreciated the participation in our global data collection that helps us improve our services and products even more.”

Leading the Future of Eye Care

VISTA’s dedication to delivering evidence-based, patient-centered solutions continues to redefine standards in ophthalmology. This latest breakthrough solidifies VISTA’s position as a leader in the field, in line with its mission: “Safely help people see their best. Changing lives.”

Through innovative treatments like E>Eye IRPL therapy, VISTA remains steadfast in transforming lives and setting new benchmarks in the delivery of exceptional eye care across Southeast Asia.

About VISTA Eye Specialist

Founded on a commitment to clinical excellence and patient-focused care, VISTA Eye Specialist is Malaysia’s premier provider of comprehensive eye health services with 18 centres across the nation. From advanced cataract surgery and LASIK to cutting-edge dry eye treatments, VISTA offers the most innovative solutions to ensure optimal vision and well-being for its patients.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/vista-eye-specialist-revolutionizes-dry-eye-treatment-with-groundbreaking-research-and-advanced-technology-302339155.html

SOURCE VISTA Eye Specialist

​ 

Previous Post

SM approaches 2025 with cautious optimism

Next Post

Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

Next Post
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • EVE Energy Hosts Inaugural Commercial Vehicle Battery Technology Day, Unveiling Innovative Open Source Battery Solutions for Full-Range of Commercial Vehicles
  • Certis unboxes ‘robocop’ as it explores use of humanoid robots
  • Certis unboxes ‘robocop’ as it explores use of humanoid robots

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved